Cite
HARVARD Citation
Pan, Q. et al. (2020). Body composition alteration and inflammation are independent predictors of survival in lung cancer patients treated with anlotinib. Clinical nutrition ESPEN. pp. 564-565. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pan, Q. et al. (2020). Body composition alteration and inflammation are independent predictors of survival in lung cancer patients treated with anlotinib. Clinical nutrition ESPEN. pp. 564-565. [Online].